SMNR
Semnur Pharmaceuticals, Inc.Company with tickers: SMNR, SMNRW
CIK
1913577
CUSIP
81686G105
Shares Outstanding
230,209,142
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-04-23 | 2026-04-20 | |
| 8-K | 2026-03-17 | 2026-03-13 | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2025-12-03 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-09-26 | 2025-09-22 | |
| 8-K | 2025-09-04 | 2025-09-03 | |
| 8-K | 2025-08-22 | 2025-08-20 | |
| 10-Q | 2025-08-15 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-07-28 | 2025-07-22 | |
| 8-K | 2025-07-11 | — | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 10-Q | 2025-05-16 | 2025-03-31 | |
| 8-K | 2025-05-12 | 2025-05-09 | |
| 8-K | 2025-04-22 | 2025-04-16 | |
| 8-K | 2025-04-16 | 2025-04-11 | |
| 8-K | 2025-04-09 | 2025-04-02 | |
| 10-K | 2025-04-02 | 2024-12-31 | |
| 8-K | 2025-03-12 | 2025-03-11 | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-12-11 | — | |
| 10-Q | 2024-11-19 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-10-11 | — | |
| 8-K | 2024-10-07 | 2024-10-02 | |
| 8-K | 2024-09-12 | 2024-09-11 | |
| 8-K | 2024-09-05 | 2024-08-30 | |
| 10-Q | 2024-08-19 | 2024-06-30 | |
| 8-K | 2024-08-09 | — | |
| 8-K | 2024-07-17 | 2024-07-15 | |
| 8-K | 2024-07-10 | — | |
| 8-K | 2024-07-05 | 2024-07-02 | |
| 8-K | 2024-06-27 | 2024-06-26 | |
| 10-Q | 2024-05-22 | 2024-03-31 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-02-27 | 2024-02-22 | |
| 8-K | 2024-01-10 | 2024-01-09 | |
| 8-K | 2023-12-29 | — | |
| 8-K | 2023-11-20 | 2023-11-17 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-11 | — | |
| 8-K | 2023-08-30 | 2023-08-29 | |
| 8-K | 2023-08-28 | 2023-08-23 | |
| 10-Q | 2023-08-15 | 2023-06-30 | |
| 8-K | 2023-08-04 | — | |
| 8-K | 2023-07-13 | — | |
| 10-Q | 2023-05-15 | 2023-03-31 |
Showing 1–50 of 61 filings